{
    "title": "MARKET REPORT: Obesity drugs maker Vivus fattened by speculation",
    "url": "https://www.dailymail.co.uk/money/markets/article-2250770/MARKET-REPORT-Obesity-drugs-maker-Vivus-fattened-speculation.html",
    "date": "2012-12-19",
    "keywords": [
        "cent",
        "market",
        "drug",
        "vivus",
        "group",
        "speculation",
        "year",
        "qsymia",
        "report",
        "obesity",
        "maker",
        "company",
        "dysfunction",
        "monday",
        "johnson",
        "astrazeneca",
        "administration",
        "fda",
        "bank",
        "fine",
        "offer",
        "share",
        "soriot",
        "target",
        "price",
        "stock",
        "majority",
        "credit",
        "stake",
        "yesterday",
        "property",
        "football",
        "club",
        "geoff",
        "foster",
        "mailonline",
        "gmt",
        "december",
        "view",
        "uk",
        "corner",
        "person",
        "body",
        "mass",
        "index",
        "measure",
        "fat",
        "weight",
        "square",
        "weightloss",
        "proposition",
        "higher",
        "york",
        "slide",
        "rule",
        "vivuss",
        "food",
        "prescription",
        "libor",
        "health",
        "week",
        "avanafil",
        "trademark",
        "name",
        "stendra",
        "viagra",
        "pfizer",
        "look",
        "attack",
        "cash",
        "region",
        "chance",
        "success",
        "pill",
        "arthritis",
        "trial",
        "strain",
        "threadbare",
        "research",
        "pipeline",
        "executive",
        "prone",
        "david",
        "brennan",
        "august",
        "buyback",
        "programme",
        "strategy",
        "growth",
        "glaxosmithkline",
        "boss",
        "andrew",
        "witty",
        "activity",
        "balance",
        "sheet",
        "panmure",
        "gordon",
        "gsk",
        "largecap"
    ],
    "category": [
        "money",
        "markets"
    ]
}